Cargando…
Changes in Newly Identified Cancer Among US Patients From Before COVID-19 Through the First Full Year of the Pandemic
This cross-sectional study updates a previous analysis of changes in rates of new cancer diagnosis among US patients during the COVID-19 pandemic.
Autores principales: | Kaufman, Harvey W., Chen, Zhen, Niles, Justin K., Fesko, Yuri A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408670/ https://www.ncbi.nlm.nih.gov/pubmed/34463748 http://dx.doi.org/10.1001/jamanetworkopen.2021.25681 |
Ejemplares similares
-
Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic
por: Kaufman, Harvey W., et al.
Publicado: (2020) -
Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S.
por: Pinto, Casey N., et al.
Publicado: (2021) -
The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020
por: Niles, Justin K., et al.
Publicado: (2021) -
Changes in ganglioside antibody positivity rates during the COVID-19 pandemic
por: Racke, Michael K., et al.
Publicado: (2022) -
Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring
por: Fragala, Maren S., et al.
Publicado: (2021)